The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.

作者: Naruji Kugimiya , Arata Nishimoto , Tohru Hosoyama , Koji Ueno , Tadahiko Enoki

DOI: 10.1111/JCMM.12531

关键词:

摘要: c-MYC overexpression is frequently observed in various cancers including colon cancer and regulates many biological activities such as aberrant cell proliferation, apoptosis, genomic instability, immortalization drug resistance. However, the mechanism by which confers resistance remains to be fully elucidated. In this study, we found that expression level primary colorectal tissues correlated with recurrence rate following 5-fluorouracil (5-FU)-based adjuvant chemotherapy. Supporting finding, of exogenous increased survival 5-FU treatment human cells, knockdown endogenous decreased it. Furthermore, ABCB5, involved Using a chromatin immunoprecipitation assay, bound ABCB5 promoter region. inhibitor (10058-F4) inhibited binding promoter, leading decrease level. expected, was 5-FU-resistant cells. Finally, using xenograft murine model, combined 10058-F4 significantly tumorigenicity nude mice compared or alone. presence absence 5-FU. contrast, alone Taken together, these results suggest through regulating

参考文章(27)
Sara K. Oster, Cynthia S.W. Ho, Erinn L. Soucie, Linda Z. Penn, The myc Oncogene: omplex Advances in Cancer Research. ,vol. 84, pp. 81- 154 ,(2002) , 10.1016/S0065-230X(02)84004-0
Jianhui Yuan, Hui Lv, Bo Peng, Chengkun Wang, Yanhui Yu, Zhimin He, None, Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer Cancer Chemotherapy and Pharmacology. ,vol. 63, pp. 1103- 1110 ,(2009) , 10.1007/S00280-008-0838-Z
Arata Nishimoto, Naruji Kugimiya, Toru Hosoyama, Tadahiko Enoki, Tao-Sheng Li, Kimikazu Hamano, JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein–protein interaction in human colon cancer cells Biochemical and Biophysical Research Communications. ,vol. 438, pp. 513- 518 ,(2013) , 10.1016/J.BBRC.2013.07.105
DR Smith, T Myint, HS Goh, Over-expression of the c-myc proto-oncogene in colorectal carcinoma. British Journal of Cancer. ,vol. 68, pp. 407- 413 ,(1993) , 10.1038/BJC.1993.350
TL Walker, JD White, WJ Esdale, MA Burton, EE DeCruz, Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression. British Journal of Cancer. ,vol. 73, pp. 610- 614 ,(1996) , 10.1038/BJC.1996.105
L. J. Goldstein, H. Galski, A. Fojo, M. Willingham, S.-L. Lai, A. Gazdar, R. Pirker, A. Green, W. Crist, G. M. Brodeur, M. Lieber, J. Cossman, M. M. Gottesman, I. Pastan, Expression of Multidrug Resistance Gene in Human Cancers Journal of the National Cancer Institute. ,vol. 81, pp. 116- 124 ,(1989) , 10.1093/JNCI/81.2.116
Marina Vita, Marie Henriksson, The Myc oncoprotein as a therapeutic target for human cancer. Seminars in Cancer Biology. ,vol. 16, pp. 318- 330 ,(2006) , 10.1016/J.SEMCANCER.2006.07.015
Mohamed-Salah I. Abaza, Amal Al-Saffar, Shorooq Al-Sawan, Rajaa Al-Attiyah, c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs. Tumor Biology. ,vol. 29, pp. 287- 303 ,(2008) , 10.1159/000156706
Brian J Wilson, Tobias Schatton, Qian Zhan, Martin Gasser, Jie Ma, Karim R Saab, Robin Schanche, Ana-Maria Waaga-Gasser, Jason S Gold, Qin Huang, George F Murphy, Markus H Frank, Natasha Y Frank, None, ABCB5 Identifies a Therapy-Refractory Tumor Cell Population in Colorectal Cancer Patients Cancer Research. ,vol. 71, pp. 5307- 5316 ,(2011) , 10.1158/0008-5472.CAN-11-0221
Antonio Porro, Michelle Haber, Daniel Diolaiti, Nunzio Iraci, Michelle Henderson, Samuele Gherardi, Emanuele Valli, Marcia A. Munoz, Chengyuan Xue, Claudia Flemming, Manfred Schwab, Jason H. Wong, Glenn M. Marshall, Giuliano Della Valle, Murray D. Norris, Giovanni Perini, Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer Cells Journal of Biological Chemistry. ,vol. 285, pp. 19532- 19543 ,(2010) , 10.1074/JBC.M109.078584